Should COVID-19 treatment and testing be free? | The Tylt
Like with all things in American healthcare, COVID-19 treatment is expensive. Recently, Gilead Sciences announced remdesivir, one of the few drugs found to be effective at treating COVID-19, will be priced at $3,120 per patient—that pricing "will make sure all patients around the world have access to this medicine." According to Bloomberg, consumer rights group Public Citizen estimates the drug could actually be produced for $1 per day of treatment through generic production.
Traditionally drug makers and health providers say the price is balanced between accessibility and paying for business costs that make the drugs and treatment available. However, critics argue that this healthcare system was already broken in normal times—the pandemic has shown that healthcare is ultimately a public health issue—it must be free and accessible for all.
Should COVID-19 treatment and testing be free?
Coronavirus: Coverage and Care